Literature DB >> 621782

Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product.

R B Luftig, Y Yoshinaka.   

Abstract

Preparations of Rauscher leukemia virus (RLV) that had relatively low, intermediate, or high levels of P70 (the gag gene product) on sodium dodecyl sulfatepolyacrylamide gel electrophoresis were examined by thin-section electron microscopy. A direct correlation was found between the number of immature virions in the RLV preparation and the amount of P70. The immature core subparticles isolated from these RLV preparations could themselves be further subdivided into two categories, based on their P70 content and negative stain morphology. Those immature cores containing a high P70/p30 ratio predominantly (85%) exhibited a highly coiled internal structure; those with a relatively low level of P70 exhibited less of an internal coiled structure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621782      PMCID: PMC353940     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

1.  Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

2.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

3.  Partial characterization of a P70 proteolytic factor that is present in purified virions of Rauscher leukemia virus (RLV).

Authors:  Y Yoshinaka; R B Luftig
Journal:  Biochem Biophys Res Commun       Date:  1977-05-09       Impact factor: 3.575

Review 4.  Remarks on the ultrastructure of type A, B, and C virus particles.

Authors:  E de Harven
Journal:  Adv Virus Res       Date:  1974       Impact factor: 9.937

5.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

6.  An electron microscope study of Rauscher leukemia virus.

Authors:  R B Luftig; S S Kilham
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

7.  gag Gene of mammalian type-C RNA tumour viruses.

Authors:  M Barbacid; J R Stephenson; S A Aaronson
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

8.  Method for reproducible large-volume production and purification of Rauscher murine leukemia virus.

Authors:  R W Johnson; A Perry; O R Robinson; G P Shibley
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

9.  High molecular weight precursor polypeptides to structural proteins of Rauscher murine leukemia virus.

Authors:  S Z Shapiro; M Strand; J T August
Journal:  J Mol Biol       Date:  1976-11-15       Impact factor: 5.469

10.  Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  8 in total

1.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

Authors:  R C Craven; R P Bennett; J W Wills
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  An assembly domain of the Rous sarcoma virus Gag protein required late in budding.

Authors:  J W Wills; C E Cameron; C B Wilson; Y Xiang; R P Bennett; J Leis
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Inhibition of murine leukemia virus Pr65gag cleavage in vitro and in vivo by hypertonic medium.

Authors:  Y Yoshinaka; R B Luftig
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

5.  Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene.

Authors:  A M Schultz; E H Rabin; S Oroszlan
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

6.  Maturation of the Gag core decreases the stability of retroviral lipid membranes.

Authors:  Candice Davidoff; Riley J Payne; Sharon H Willis; Benjamin J Doranz; Joseph B Rucker
Journal:  Virology       Date:  2012-09-17       Impact factor: 3.616

7.  In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

Authors:  T Goto; K Ikuta; J J Zhang; C Morita; K Sano; M Komatsu; H Fujita; S Kato; M Nakai
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.